Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

被引:68
|
作者
Haines, David E. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha [2 ]
机构
[1] Oakland Univ, Dept Cardiovasc Med, William Beaumont Sch Med, Beaumont Hosp,Heart Rhythm Ctr, Royal Oak, MI 48073 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
complications; death; implantable cardioverter-defibrillators; outcome assessment; registries; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; PACEMAKER; OUTCOMES;
D O I
10.1161/CIRCULATIONAHA.110.959676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age >= 70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen >30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of <= 5 (8.4% of the population) to 8.4% among patients with >= 19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure. (Circulation. 2011;123:2069-2076.)
引用
收藏
页码:2069 / 2076
页数:8
相关论文
共 50 条
  • [41] Implantable cardioverter-defibrillator therapy of short QT syndrome is associated with an inherent risk of inappropiate implantable cardioverter-defibrillator discharges
    Schimpf, R
    Wolpert, C
    Bianchi, F
    Giustetto, C
    Bauersfeld, U
    Gaita, F
    Borggrefe, M
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 28 - 28
  • [42] Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures
    Resnic, Frederic S.
    Majithia, Arjun
    Dhruva, Sanket S.
    Ssemaganda, Henry
    Robbins, Susan
    Marinac-Dabic, Danica
    Hewitt, Kathleen
    Ohno-Machado, Lucila
    Reynolds, Matthew R.
    Matheny, Michael E.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (04):
  • [43] A subcutaneous implantable cardioverter-defibrillator - the first implantation in Poland
    Kaczmarek, Krzysztof
    Zwolinski, Radoslaw
    Bartczak, Karol
    Ptaszynski, Pawel
    Wranicz, Jerzy Krzysztof
    [J]. Kardiologia Polska, 2015, 73 (01) : 62 - 62
  • [44] External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant
    Dell'Era, Gabriele
    Magnani, Andrea
    Occhetta, Eraldo
    [J]. EUROPACE, 2015, 17 (11): : 1726 - 1726
  • [45] THE SURGICAL ASPECTS OF AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION
    WATKINS, L
    TAYLOR, E
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (05): : 953 - 960
  • [46] Implantable Cardioverter-Defibrillator Implantation in a Patient with Atrial Standstill
    Park, So Ra
    Kwak, Choong Hwan
    Kang, Young Ran
    Seo, Myung Ki
    Kang, Min Kyung
    Cho, Jung Hyun
    Ahn, Yeon Jeong
    Hwang, Jin Yong
    [J]. YONSEI MEDICAL JOURNAL, 2009, 50 (01) : 156 - 159
  • [47] IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - PATIENT SELECTION AND IMPLANTATION PROTOCOL
    REID, PR
    GRIFFITH, LSC
    MOWER, MM
    PLATIA, EV
    WATKINS, L
    JUANTEGUY, J
    MIROWSKI, M
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1984, 7 (06): : 1338 - 1344
  • [48] Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation
    Da Rosa, Michael R.
    Sapp, John L.
    Howlett, Jonathan G.
    Falkenham, Alec
    Legare, Jean-Francois
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (12): : 1336 - 1339
  • [49] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - TECHNIQUES OF IMPLANTATION AND RESULTS
    THURER, RJ
    LUCERI, RM
    BOLOOKI, H
    [J]. ANNALS OF THORACIC SURGERY, 1986, 42 (02): : 143 - 147
  • [50] MORTALITY BENEFITS AND THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    SWEENEY, MO
    RUSKIN, JN
    [J]. CIRCULATION, 1994, 89 (04) : 1851 - 1858